An interesting question recently arose from our launch readiness work for a rare disease client. The question was “Do rare disease patients and caregivers really require more manufacturer support than cancer patients?” My immediate answer was “Yes”, which lead to some disbelieving faces. If you think about it, I understand the skepticism. For example:
Are rare disease patients sicker or do they fighter harder for their life than a cancer patient? – No.
Is it any harder for rare disease patients and caregivers to afford their care than cancer patients? – No, probably not.
Why then do I say that rare disease patients and caregivers require more manufacturer support? There were two main reasons supporting my belief. Read On